Transaction in Own Shares

RNS Number : 9468A
Glenveagh Properties PLC
07 June 2021
 

 

Glenveagh Properties plc

 

Transaction in Own Shares

 

 

Glenveagh Properties plc ("Glenveagh") announces that on 04 June 2021 it purchased the following number of its ordinary shares (the "ordinary shares") on the London Stock Exchange and/or Euronext Dublin, from Glenveagh's broker J&E Davy.

 


Euronext Dublin

Number of ordinary shares purchased: 

500,000

Highest price paid per share:

€0.981

Lowest price paid per share:

€0.977

Volume weighted average price paid:

€0.9795



 

The purchases form part of the Glenveagh's share buyback programme announced on 28 May 2021.

 

Following settlement and cancellation of the above transactions, Glenveagh will have 868,483,550 ordinary shares in issue. Glenveagh holds nil ordinary shares in treasury. 

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (also in force in the UK, from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by J&E Davy on behalf of Glenveagh as part of the buyback programme is scheduled to this announcement.

 

Contact:

Chloe McCarthy

Group Company Secretary

Tel: +353 (1) 556 5600 

 

 

Issuer name:


Glenveagh Properties plc


LEI


635400QUQ2YYGMOAK834


ISIN:


IE00BD6JX574


Intermediary name:

J&E Davy


Intermediary code:

DAVYIE21



Time zone:


BST



Currency:


EUR


 

 

Euronext Dublin

 

Number of Shares

Gross Price

Currency

Trade Time

Exchange

Trade ID

50000

0.981

EUR

11:30:37

ISE

00034966350TRLO1-1 

250000

0.98

EUR

11:41:50

ISE

00034966428TRLO1-1 

150000

0.979

EUR

15:48:00

ISE

00034969676TRLO1-1 

50000

0.977

EUR

16:12:24

ISE

00034970384TRLO1-1 

500000

0.9795





 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZLFBFQLFBBL
UK 100

Latest directors dealings